Ludwig-Maximilians-Universität München

Kutatók

• MSMarion Subklewe

Futó vizsgálatok

• Még nem toboroz

  Stratification and Treatment in Early Psychosis Study -ASSIST

  NCT07326124· 3. fázis· University of Oxford· Forrás

• Még nem toboroz

  A Phase 1/2/3 Study of ATSN-201 Gene Therapy in Subjects with RS1-Associated X linked Retinoschisis

  NCT05878860· 3. fázis· Atsena Therapeutics Inc.· Forrás

• Toboroz

  Stratification and Treatment in Early Psychosis Study - ENHANCE

  NCT06778564· 3. fázis· University of Oxford· Forrás

• Toboroz

  Dehydroepiandrosterone (DHEA) as Augmentation of Standard Antidepressants in Treatment-resistant Depression.

  NCT07843927· 3. fázis· Charite University, Berlin, Germany· Forrás

• Toboroz

  Establishing a Reference Framework for Outcomes After Machine-Preserved Liver Transplantation in Europe

  NCT07585890· University Medical Center Groningen· Forrás

• Toboroz

  TRICuspid Intervention and Invasive Hemodynamic Monitoring in Heart Failure

  NCT07442903· LMU Klinikum· Forrás

• Fut, nem toboroz

  COMBINED PSMA-PET/CT AND MRI STAGING IN INTERMEDIATE AND HIGH-RISK PATIENTS PROSTATA-CANCER (COMBINE-P)

  NCT07455097· Heinrich-Heine University, Duesseldorf· Forrás

• Toboroz

  A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or B

  NCT07285460· 3. fázis· Sanofi· Forrás

• Még nem toboroz

  An Adaptive Open-label Multicentre Phase 1/2 Trial, to Determine the Recommended Phase 2 Dose of CCTx-001, and to Assess Safety, Tolerability, and Clinical Activity in Patients With Relapsed/Refractory Acute Myeloid Leukaemia

  NCT06281847· 1/2. fázis· Advesya SAS· Forrás

• Még nem toboroz

  A Phase 2 Trial Evaluating the Effects of Thiethylperazine as diagnostic tool and therapeutic agent in Patients Diagnosed with an Early Stage of Alzheimer's disease

  2022-501137-23-00· 2. fázis· Immungenetics AG· Forrás

• Toboroz

  Phase 2 Study of ADX-038 in Participants With Geographic Atrophy

  NCT06990269· 2. fázis· ADARx Pharmaceuticals, Inc.· Forrás

• Toboroz

  PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis

  NCT06855329· University of Massachusetts, Worcester· Forrás

• Fut, nem toboroz

  A Study of 2 Doses of Remigromig (EYE103) Compared With Ranibizumab (0.5 mg) in Participants With DME

  NCT06957080· 2/3. fázis· EyeBiotech Ltd.· Forrás

• Toboroz

  Fast Discharge After Acute Myocardial Infarction Discharge MI

  NCT06744322· Medical University Innsbruck· Forrás

• Fut, nem toboroz

  A randomized study to evaluate the Efficacy and Safety of Intravitreal EYE103 Compared to Anti-VEGF (in patients with Diabetic Macular Edema)

  2024-510944-30-00· 2/3. fázis· Eyebiotech Limited· Forrás

• Toboroz

  CRS Questionnaire Validation Project

  NCT06970977· The European Forum for Research and Education in Allergy and Airway Diseases· Forrás

• Fut, nem toboroz

  Efficacy and Safety of GemCis Plus Trastuzumab Plus Pembrolizumab in Previously Untreated HER2-positive Biliary Tract Cancer

  NCT06178445· 2. fázis· Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest· Forrás

• Toboroz

  CARE1: FIRST LINE RANDOMISED STUDY PLATFORM TO OPTIMIZE TREATMENT IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA

  2023-503317-29-00· 3. fázis· Institut Gustave Roussy· Forrás

• Toboroz

  LUPUS-BEST - Treat-to-target in Systemic Lupus Erythematosus

  NCT05714930· Heinrich-Heine University, Duesseldorf· Forrás

• Toboroz

  Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMOSD

  NCT05566769· Ad scientiam· Forrás

• Toboroz

  Safety and Tolerability of Intravitreal Administration of VG901 in Patients With Retinitis Pigmentosa Due to Mutations in the CNGA1 Gene

  NCT06291935· 1. fázis· VeonGen Therapeutics GmbH· Forrás

• Toboroz

  Clinical Study Evaluating Pharmacogenomics-informed Pharmacotherapy Versus Dosing as Usual in Psychiatric Disorders

  NCT05656469· 4. fázis· Parnassia Groep· Forrás

• Toboroz

  DERIVO® 2heal® Study: Clinical Safety and Efficacy of the DERIVO® 2heal® Embolisation Device

  NCT05543447· Acandis GmbH· Forrás

• Toboroz

  A Pivotal Study of N-Acetyl-L-Leucine on Niemann-Pick Disease Type C

  NCT05163288· 3. fázis· IntraBio Inc· Forrás

• Toboroz

  Inhalation therapy in adult bronchiectasis patients with new asymptomatic Pseudomonas aeruginosa infection– an open-label, proof of concept - randomized controlled trial

  2023-509277-22-00· 2. fázis· Philipps-Universitaet Marburg· Forrás

• Fut, nem toboroz

  Non-interventional Study on Osilodrostat in Patients With Endogenous Cushing's Syndrome

  NCT05382156· RECORDATI GROUP· Forrás

• Fut, nem toboroz

  AMP SCZ® Observational Study: PREDICT-DPACC

  NCT05905003· Brigham and Women's Hospital· Forrás

• Fut, nem toboroz

  Pharmacokinetics, Safety and Efficacy of the Selumetinib Granule Formulation in Children Aged ≥1 to <7 Years With NF1-related Symptomatic, Inoperable PN

  NCT05309668· 1/2. fázis· AstraZeneca· Forrás

• Fut, nem toboroz

  Prognostic Role of Circulating Tumor DNA in Resectable Pancreatic Cancer

  NCT04246203· Ludwig-Maximilians - University of Munich· Forrás

• Toboroz

  High Dose Steroids in Children With Stroke

  NCT04873583· 3. fázis· Insel Gruppe AG, University Hospital Bern· Forrás

• Fut, nem toboroz

  A Study to Investigate the Efficacy and Safety of Trastuzumab Deruxtecan as the First Treatment Option for Unresectable, Locally Advanced/Metastatic Non-Small Cell Lung Cancer With HER2 Mutations

  NCT05048797· 3. fázis· AstraZeneca· Forrás

• Toboroz

  ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

  NCT05059444· Guardant Health, Inc.· Forrás

• Fut, nem toboroz

  A Study of the Efficacy, Safety, and Pharmacokinetics of a 36-Week Refill Regimen for the Port Delivery System With Ranibizumab in Patients With Neovascular Age-Related Macular Degeneration (Velodrome)

  NCT04657289· 3. fázis· Hoffmann-La Roche· Forrás

• Toboroz

  Vitrectomy, Subretinal Tissue Plasminogen Activator (TPA) and Intravitreal Gas for Submacular Haemorrhage Secondary to Exudative (Wet) Age-related Macular Degeneration (TIGER).

  NCT04663750· 3. fázis· King's College Hospital NHS Trust· Forrás

• Fut, nem toboroz

  Optimal Timing of Transcatheter Aortic Valve Implantation and Percutaneous Coronary Intervention - The TAVI PCI Trial

  NCT04310046· University of Zurich· Forrás

• Fut, nem toboroz

  Comparison of Carboplatin and Cisplatin in patients with extracranial malignant germ cell tumours

  2023-507582-25-00· 3. fázis· Rheinische Friedrich-Wilhelms-Universitaet Bonn· Forrás

• Toboroz

  Extension Study for the Port Delivery System With Ranibizumab (Portal)

  NCT03683251· 3. fázis· Hoffmann-La Roche· Forrás

• Fut, nem toboroz

  Reducing Lung CongestIon Symptoms in Advanced Heart Failure

  NCT03499236· V-Wave Ltd· Forrás

• Fut, nem toboroz

  Paediatric Hepatic International Tumour Trial

  NCT03017326· 3. fázis· University of Birmingham· Forrás

• Toboroz

  REtroperitoneal SArcoma Registry: an International Prospective Initiative

  NCT03838718· Fondazione IRCCS Istituto Nazionale dei Tumori, Milano· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Időskori makuladegeneráció3 toboroz
• Skizofrénia3 toboroz
• Depresszió2 toboroz
• Retinitis pigmentosa2 toboroz
• Vesedaganat2 toboroz
• Akut mieloid leukémia (AML)1 toboroz
• Alzheimer-kór1 toboroz
• Bipoláris zavar1 toboroz
• Brain aneurysm1 toboroz
• Bronchiectasis1 toboroz
• Chronic rhinosinusitis with nasal polyps1 toboroz
• Fej-nyaki daganatok1 toboroz
• Frontotemporális demencia1 toboroz
• Gyermekkori daganatok1 toboroz
• Gyomor- és nyelőcsőrák1 toboroz
• Hasnyálmirigyrák1 toboroz
• Hemofília1 toboroz
• Hólyagrák1 toboroz
• Idiopátiás tüdőfibrózis1 toboroz
• Koszorúér-betegség1 toboroz
• Liver cirrhosis1 toboroz
• Lupus (SLE)1 toboroz
• Máj- és epeúti rák1 toboroz
• Méhtestrák1 toboroz
• Melanóma1 toboroz
• Neuromyelitis optica (NMOSD)1 toboroz
• Petefészekrák1 toboroz
• Stroke (szélütés)1 toboroz
• Szarkóma1 toboroz
• Szívelégtelenség1 toboroz
• Tüdőrák1 toboroz
• Vastagbélrák1 toboroz

Lezárt vizsgálatok

• Fut, nem toboroz

  A Phase 3 study of belrestotug plus dostarlimab compared with placebo plus pembrolizumab in previously untreated PD L1 high NSCLC

  2023-504753-12-00· 3. fázis· Glaxosmithkline Research & Development Limited· Forrás

• Lezárult

  Mi2000 Totally Implantable Cochlear Implant (Mi2000 TICI)

  NCT06459765· MED-EL Elektromedizinische Geräte GmbH· Forrás

• Lezárult

  A Two-Part Study to Assess the Effectiveness, Safety, and Blood Levels of Repeat Doses of Inhaled ETD001 in People with Cystic Fibrosis

  2023-504092-25-00· 2. fázis· Enterprise Therapeutics Limited· Forrás

• Lezárult

  Efficacy, Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BIA 28-6156 in GBA-PD

  NCT05819359· 2. fázis· Bial R&D Investments, S.A.· Forrás

• Fut, nem toboroz

  A Study Evaluating the Efficacy and Safety of Multiple Therapies in Cohorts of Participants With Locally Advanced, Unresectable, Stage III Non-Small Cell Lung Cancer (NSCLC)

  NCT05170204· 3. fázis· Hoffmann-La Roche· Forrás

• Lezárult

  Avacincaptad Pegol Open-Label Extension for Patients With Geographic Atrophy

  NCT05536297· 3. fázis· Astellas Pharma Global Development, Inc.· Forrás

• Fut, nem toboroz

  A Study of Dato-DXd Versus Investigator's Choice Chemotherapy in Patients With Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer, Who Are Not Candidates for PD-1/PD-L1 Inhibitor Therapy (TROPION-Breast02)

  NCT05374512· 3. fázis· AstraZeneca· Forrás

• Fut, nem toboroz

  A Global Study to Assess the Effects of Osimertinib in Participants With EGFRm Stage IA2-IA3 NSCLC Following Complete Tumour Resection

  NCT05120349· 3. fázis· AstraZeneca· Forrás

• Lezárult

  Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of Exacerbations.

  NCT05158387· 3. fázis· AstraZeneca· Forrás

• Leállították

  MR-Guided Adaptive SBRT of Primary Tumor for Pain Control in Metastatic PDAC

  NCT05114213· 2. fázis· Ludwig-Maximilians - University of Munich· Forrás

• Fut, nem toboroz

  A Long-term Extension Study of Ustekinumab in Pediatric Participants

  NCT05092269· 3. fázis· Janssen Research & Development, LLC· Forrás

• Lezárult

  A Study of Ustekinumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease

  NCT04673357· 3. fázis· Janssen Research & Development, LLC· Forrás

• Lezárult

  A Study of Ustekinumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis (UC)

  NCT04630028· 3. fázis· Janssen Research & Development, LLC· Forrás

• Lezárult

  Treatment of Major Depressive Disorder With Bilateral Theta Burst Stimulation

  NCT04392947· University Hospital Tuebingen· Forrás

• Lezárult

  Safety and Tolerance of Epigenetic and Immunomodulating Drugs Combined With Chemotherapeutics in Patients Suffering From Advanced Pancreatic Cancer

  NCT04257448· 1/2. fázis· GWT-TUD GmbH· Forrás

• Lezárult

  A Study of Brigatinib in Participants With Anaplastic Lymphoma Kinase-Positive (ALK+), Advanced Non-Small-Cell Lung Cancer (NSCLC) Progressed on Alectinib or Ceritinib

  NCT03535740· 2. fázis· Ariad Pharmaceuticals· Forrás

• Lezárult

  PTSD After ICU Survival - Caring for Patients With Traumatic Stress Sequelae Following Intensive Medical Care

  NCT03315390· Ludwig-Maximilians - University of Munich· Forrás

• Lezárult

  Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis

  NCT03422822· 3. fázis· Pfizer· Forrás

• Lezárult

  Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs Placebo Plus Chemotherapy as Neoadjuvant Therapy and Pembrolizumab vs Placebo as Adjuvant Therapy in Participants With Triple Negative Breast Cancer (TNBC) (MK-3475-522/KEYNOTE-522)

  NCT03036488· 3. fázis· Merck Sharp & Dohme LLC· Forrás

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

• Alzheimer-kór215 munka · 1 vizsgálat
• Stroke (szélütés)192 munka · 1 vizsgálat
• Elhízás125 munka · 0 vizsgálat
• Szívelégtelenség117 munka · 2 vizsgálat
• Tüdőrák105 munka · 6 vizsgálat
• Skizofrénia102 munka · 4 vizsgálat
• HIV-fertőzés88 munka · 0 vizsgálat
• Asztma86 munka · 0 vizsgálat
• Parkinson-kór79 munka · 1 vizsgálat
• Glioblasztóma77 munka · 0 vizsgálat
• Prosztatarák73 munka · 1 vizsgálat
• Melanóma64 munka · 1 vizsgálat
• Epilepszia61 munka · 0 vizsgálat
• Vastagbélrák58 munka · 1 vizsgálat
• Tuberkulózis57 munka · 0 vizsgálat
• Koszorúér-betegség54 munka · 2 vizsgálat
• Atópiás dermatitisz (ekcéma)54 munka · 1 vizsgálat
• Szarkóma51 munka · 1 vizsgálat
• Krónikus vesebetegség49 munka · 0 vizsgálat
• Bipoláris zavar47 munka · 1 vizsgálat
• Hólyagrák46 munka · 1 vizsgálat
• Akut mieloid leukémia (AML)45 munka · 1 vizsgálat
• Sclerosis multiplex (SM)45 munka · 0 vizsgálat
• Depresszió42 munka · 3 vizsgálat
• Cushing's syndrome41 munka · 1 vizsgálat
• Frontotemporális demencia39 munka · 1 vizsgálat
• Idiopátiás tüdőfibrózis38 munka · 1 vizsgálat
• Osteoarthritis37 munka · 0 vizsgálat
• Deep vein thrombosis and pulmonary embolism36 munka · 0 vizsgálat
• Hasnyálmirigyrák33 munka · 4 vizsgálat